Gender
Visit number vs HDL Cholesterol
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 49 | 42.6 | ± 11.0 | 40.0 | 24.0 | 80.0 | - | 49 |
9-Month Followup | 43 | 45.2 | ± 11.8 | 43.0 | 27.0 | 79.0 | - | 43 |
18-Month Followup | 40 | 46.6 | ± 12.9 | 46.0 | 28.0 | 81.0 | - | 40 |
Randomized treatment arm vs HDL Cholesterol
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 42.6 | ± 11.0 | 40.0 | 24.0 | 80.0 | - | 49 |
Laparoscopic Gastric Banding (LGB) | 28 | 46.6 | ± 11.6 | 45.5 | 32.0 | 80.0 | - | 28 |
Continuous Positive Airway Pressure (CPAP) | 21 | 37.2 | ± 7.4 | 35.0 | 24.0 | 58.0 | - | 21 |
Randomized treatment arm vs HDL Cholesterol
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 45.2 | ± 11.8 | 43.0 | 27.0 | 79.0 | - | 43 |
Laparoscopic Gastric Banding (LGB) | 25 | 49.1 | ± 12.4 | 48.0 | 27.0 | 79.0 | - | 25 |
Continuous Positive Airway Pressure (CPAP) | 18 | 39.7 | ± 8.5 | 39.5 | 28.0 | 59.0 | - | 18 |
Randomized treatment arm vs HDL Cholesterol
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 46.6 | ± 12.9 | 46.0 | 28.0 | 81.0 | - | 40 |
Laparoscopic Gastric Banding (LGB) | 24 | 50.9 | ± 13.1 | 49.5 | 31.0 | 81.0 | - | 24 |
Continuous Positive Airway Pressure (CPAP) | 16 | 40.1 | ± 9.7 | 39.0 | 28.0 | 57.0 | - | 16 |
Age of the participant vs HDL Cholesterol
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 42.6 | ± 11.0 | 40.0 | 24.0 | 80.0 | - | 49 |
27.0 to 45.0 years | 13 | 38.2 | ± 5.7 | 38.0 | 31.0 | 47.0 | - | 13 |
46.0 to 50.0 years | 12 | 46.2 | ± 11.2 | 44.0 | 32.0 | 63.0 | - | 12 |
51.0 to 56.0 years | 12 | 41.8 | ± 11.6 | 40.0 | 24.0 | 66.0 | - | 12 |
57.0 to 65.0 years | 12 | 44.6 | ± 13.6 | 44.0 | 31.0 | 80.0 | - | 12 |
Age of the participant vs HDL Cholesterol
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 45.2 | ± 11.8 | 43.0 | 27.0 | 79.0 | - | 43 |
28.0 to 47.0 years | 11 | 40.5 | ± 8.2 | 40.0 | 30.0 | 56.0 | - | 11 |
47.0 to 52.0 years | 11 | 46.1 | ± 12.8 | 48.0 | 27.0 | 67.0 | - | 11 |
52.0 to 58.0 years | 11 | 45.5 | ± 10.9 | 43.0 | 28.0 | 64.0 | - | 11 |
58.0 to 65.0 years | 10 | 48.9 | ± 14.6 | 47.5 | 29.0 | 79.0 | - | 10 |
Age of the participant vs HDL Cholesterol
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 46.6 | ± 12.9 | 46.0 | 28.0 | 81.0 | - | 40 |
29.0 to 46.0 years | 10 | 38.7 | ± 8.5 | 36.0 | 29.0 | 53.0 | - | 10 |
47.0 to 52.0 years | 10 | 49.8 | ± 11.0 | 53.5 | 31.0 | 68.0 | - | 10 |
53.0 to 58.0 years | 10 | 47.5 | ± 10.7 | 49.5 | 29.0 | 62.0 | - | 10 |
58.0 to 65.0 years | 10 | 50.4 | ± 17.7 | 47.5 | 28.0 | 81.0 | - | 10 |
Gender of the participant vs HDL Cholesterol
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 42.6 | ± 11.0 | 40.0 | 24.0 | 80.0 | - | 49 |
Male | 28 | 38.3 | ± 7.7 | 35.0 | 24.0 | 63.0 | - | 28 |
Female | 21 | 48.3 | ± 12.1 | 47.0 | 31.0 | 80.0 | - | 21 |
Gender of the participant vs HDL Cholesterol
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 45.2 | ± 11.8 | 43.0 | 27.0 | 79.0 | - | 43 |
Male | 25 | 41.2 | ± 10.6 | 40.0 | 27.0 | 67.0 | - | 25 |
Female | 18 | 50.7 | ± 11.3 | 49.5 | 34.0 | 79.0 | - | 18 |
Gender of the participant vs HDL Cholesterol
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 46.6 | ± 12.9 | 46.0 | 28.0 | 81.0 | - | 40 |
Male | 25 | 41.8 | ± 10.1 | 40.0 | 28.0 | 60.0 | - | 25 |
Female | 15 | 54.6 | ± 13.3 | 53.0 | 34.0 | 81.0 | - | 15 |
Race of the participant vs HDL Cholesterol
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 46 | 42.8 | ± 11.2 | 40.5 | 24.0 | 80.0 | - | 46 |
white | 35 | 43.2 | ± 12.1 | 42.0 | 24.0 | 80.0 | - | 35 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 9 | 42.4 | ± 8.8 | 40.0 | 32.0 | 57.0 | - | 9 |
asian | 2 | 36.5 | ± 2.1 | 36.5 | 35.0 | 38.0 | - | 2 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs HDL Cholesterol
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 45.7 | ± 11.9 | 43.5 | 27.0 | 79.0 | - | 40 |
white | 31 | 46.1 | ± 12.9 | 43.0 | 27.0 | 79.0 | - | 31 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 8 | 43.8 | ± 8.9 | 43.5 | 32.0 | 59.0 | - | 8 |
asian | 1 | 47.0 | - | 47.0 | 47.0 | 47.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs HDL Cholesterol
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 37 | 47.2 | ± 12.9 | 47.0 | 29.0 | 81.0 | - | 37 |
white | 29 | 47.7 | ± 13.6 | 48.0 | 29.0 | 81.0 | - | 29 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 7 | 46.4 | ± 11.6 | 43.0 | 31.0 | 65.0 | - | 7 |
asian | 1 | 41.0 | - | 41.0 | 41.0 | 41.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |